Ge, Gaoxiang
Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor. [electronic resource]
- Proceedings of the National Academy of Sciences of the United States of America Jun 2007
- 10010-5 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
ISSN: 0027-8424
Standard No.: 10.1073/pnas.0704179104 doi
Subjects--Topical Terms: Amino Acid Sequence Amino Acid Substitution Angiogenesis Inhibitors--chemistry Animals Bone Morphogenetic Protein 1 Bone Morphogenetic Proteins--chemistry Cell Proliferation--drug effects Cells, Cultured Chorioallantoic Membrane--drug effects Dose-Response Relationship, Drug Embryo, Mammalian--cytology Endothelial Cells--drug effects Endothelium, Vascular--cytology Fibroblasts--cytology Genes, Reporter Growth Hormone--genetics Homozygote Humans Luciferases--metabolism Metalloendopeptidases--chemistry Mice Mitogen-Activated Protein Kinase 1--antagonists & inhibitors Mitogen-Activated Protein Kinase 3--antagonists & inhibitors Molecular Weight Peptide Library Phosphorylation--drug effects Prolactin--metabolism Protein Processing, Post-Translational Recombinant Proteins--metabolism Substrate Specificity Umbilical Veins--cytology